Top 5 Heal Care Stocks To Watch Right Now

Getty Images For the historically minded, the political battles of the last few years may have induced an especially vertiginous bout of deja vu. After all, many of the big debates currently roiling our government — including those over the minimum wage, health care, college tuition and unemployment — are nothing new. For decades, politicians and pundits have hashed over these topics, arguing over the appropriate breadth and depth of America’s social safety net. On Salon, Paul Buchheit offers an interesting rundown of government policies that hurt children, students, the elderly, wage earners, women, minorities, the sick and disabled, and the homeless — a collection of constituencies that Buchheit calls “the eight biggest victims of America’s predatory capitalism.” Very succinctly, but with a great deal of solid evidence, he lays out his argument that, over the past few decades, the United States has de-invested from these groups … with appalling results. There’s a lot of room to disagree with Buchheit. Among other things, his categories have a great deal of overlap, and one could argue that he cherry-picks a great deal of his evidence. On the other hand, it’s also hard to ignore America’s recent attempts to balance the budget by slashing holes in the social safety net. Buchheit’s article is a reminder that governmental “savings” rarely come without a cost — and that the ones left holding the bill are often the people who have the most to lose.

Top 5 Heal Care Stocks To Watch Right Now: Superconductor Technologies Inc.(SCON)

Superconductor Technologies Inc. engages in the development and production of high temperature superconducting (HTS) materials and associated technologies worldwide. The company is leveraging its technologies, including HTS materials and cryogenics, to develop second generation (2G) HTS wire for power applications. Its HTS-based products play a role in emerging power generation, conversion, and distribution applications by enhancing grid reliability and efficiency. The company?s flagship wireless product, SuperLink, combines a specialized filter using patented HTS technology with a proprietary cryogenic cooler and a low-noise amplifier. Its commercial product offerings include SuperLink, a receiver front-end HTS wireless filter system that eliminates out-of-band interference for wireless base stations; AmpLink, a ground-mounted unit for wireless base stations that includes a high-performance amplifier and up to six dual duplexers; and SuperPlex, a multiplexer that provide s low insertion loss and cross-band isolation. The company also grants the U.S. government a royalty-free, non-exclusive, and nontransferable license to use its intellectual property. It sells its products primarily to wireless carriers through direct sales force in the United States, as well as through indirect channels internationally. The company was founded in 1987 and is headquartered in Santa Barbara, California.

Advisors’ Opinion:

  • [By Bryan Murphy]

    A week and a half ago, not to mention a couple of months ago, I suggested Superconductor Technologies, Inc. (NASDAQ:SCON) was a budding bullish play worthy of your attention. I get the suspicion that while more than a handful of traders read my take, the vast majority of the people who read that commentary weren’t as impressed with (SCON) as I was. That’s fine. Yet, being a diehard – and perhaps being a glutton for punishment – this is one of those trading ideas I can’t let go of, mostly because Superconductor Technologies refuse to give up. Thing is, the stock’s given me some new bullish fodder to use since the last look back on January 6th.

  • [By Bryan Murphy]

    It’s not the kind of thing anybody would have expected to hear, or read, five months ago, but Superconductor Technologies, Inc. (NASDAQ:SCON) is close to becoming one of the market’s best bullish short-term bets. Yes, we’re talking about the same Superconductor Technologies that plunged from $2.57 to $1.66 in August – hitting new lows in the process – on news that the company was issuing $12 million worth of new stock… right in front of news that SCON booked another significant quarterly loss.  By November, the disaster’s final tally was officially recorded – an 82% plunge in the prior quarter’s revenue for SCON. As they say though, nothing lasts forever. That includes a malaise that can hold a stock down. Indeed, it’s looking like SCON is about to make an explosive move higher. 

  • [By Bryan Murphy]

    Just for the record, Superconductor Technologies, Inc. (NASDAQ:SCON) isn’t over the hump yet. But, given the likelihood that it could get over the hump with little to no fanfare, now’s the time to put SCON on your radar.

Top 5 Heal Care Stocks To Watch Right Now: Alere Inc (ALR)

Alere Inc., incorporated on May 11, 2001, is a provider of point-of-care diagnostics and services. The Company’s products and services help healthcare practitioners make treatment decisions and improve outcomes for individuals living with chronic disease. The Company’s portfolio also includes a range of health information solutions that access to critical health data, provide clinical decision support, and facilitate performance reporting and analysis. The Company’s segment includes professional diagnostics, health information solutions and consumer diagnostics. The Company distributes its professional diagnostic products to hospitals, reference laboratories, physician offices and other point-of-care settings through an worldwide distribution networks. In February 2013, the Company acquired Epocal, Inc.

Professional Diagnostics

Professional diagnostics are generally designed to assist medical professionals in both preventative and interventiona l medicine, and include testing and monitoring performed in hospitals, laboratories and doctors’ offices and, increasingly, patient self-testing, which the Company defines as testing or monitoring performed at home under the supervision of a medical professional. Professional diagnostic products provide for qualitative or quantitative analysis of patient samples for evidence of a specific medical condition, disease state or toxicological state or to measure response to therapy. The point-of-care market for rapid diagnostic products includes all areas where a patient is assessed or diagnosed, including hospitals, laboratories, physician offices, specialized mobile clinics, emergency rooms, rapid-response laboratories and patient health screening locations.

The Company’s Alere Cholestech LDX System is a point-of-care monitor of blood cholesterol and related lipids which is used to test patients at risk of, or suffering from, heart disease and related conditions. T he Alere Cholestech LDX System makes it possible to provide ! a complete lipid profile with tests for total cholesterol, high-density lipoprotein cholesterol (HDL) and low-density lipoprotein cholesterol (LDL), triglycerides, and glucose. The Company’s Alere INRatio System is an easy-to-use, hand-held blood coagulation monitoring system for use by patients and healthcare professionals in the management of warfarin, a commonly prescribed medication used to prevent blood clots. The Company also offers the epoc Blood Analysis System for bloods gas, electrolyte and metabolite testing, which is manufactured by its recently acquired Epocal division. The epoc (enterprise point-of-care) platform is a point-of-care analysis system which provides Wireless bedside blood gas, electrolyte and metabolite measurement testing solutions and complements the Company’s Alere Triage products in cardiology and emergency room settings.

The Company develops and markets a range of point-of-care tests for influenza A/B, RSV, strep throat, pneumonia , C. difficile, infectious mononucleosis, HIV, herpes simplex virus (HSV-2), hepatitis C (HCV), hepatitis B (HBV), malaria, lyme disease, Chlamydia, H. pylori, rubella and other infectious diseases. The Company’s tests for infectious disease are sold under brand names that include Alere, Alere Determine, Acceava, BinaxNOW, Clearview, DoubleCheckGold, Panbio, SD, TECHLAB and Alere TestPack. In addition to point-of-care products, the Company also offers a line of indirect fluorescent antibody, or IFA, assays for over 20 viral, bacterial and autoimmune diseases, a full line of serology diagnostic products covering a range of disease categories and over 50 enzyme-linked immunosorbent assay (ELISA), tests for a range of infectious and autoimmune diseases, as well as a full line of automated instrumentation for processing ELISA tests.

The Company offers laboratory-based testing services throughout Europe under the name Alere Toxicology, formerly Concateno, and in the United States under the names Alere Toxicology Services, or! Alere To! xicology, and Redwood Toxicology Laboratory, or Redwood. The Company offers point-of-care diabetes products, including its Afinion Analyzer System and its NycoCard System. The Company’s Alere Connect products include HealthPAL and HealthCOM.

Health Information Solutions

The Company’s health information solutions are designed to provide physicians with actionable data that allows them to make more decisions in real time, deliver quality care, and put the individuals they treat on a pathway to better health. The Company offers a range of software-based analytics, clinical decision support tools, and accountable cares programs that enable healthcare providers to initiate earlier interventions, personalize treatment plans, lower costs by reducing hospital readmissions, and measure improvements in outcomes at both a patient and population level. With this range of scalable solutions, the Company is able to support healthcare practitioners in the transit ion to accountable care, as well as in meeting the new pay-for-performance guidelines set by the Centers for Medicare & Medicaid Services (CMS).

The Company’s Women’s and Children’s Health division delivers a range of obstetrical care services that range from risk assessments focused on identifying women who may experience pregnancy complications to a neonatal program that supports early infant care management. The Company offers home-based obstetrical monitoring for pregnant women with medical or pregnancy-related problems that could puts their health or the health of their babies at risk. The Company also delivers telephonic and home-based nursing services that support improved clinical outcomes. The Company offers a suite of integrated wellness programs and resources that is designed to reduce participant health risks and healthcare-related costs. The Company’s wellness programs include screening for risk factors associated with chronic disease, particularly tobacco use, poor nutrition, physical inactivity, and chron! ic stress! .

The Company offers services designed to support anticoagulation management for patients who takes warfarin to control their risk for stroke and clotting disorders. Alere Home Monitoring, the Company’s patient self-testing business, assists patients in acquiring home INR monitors and with insurance coverage determinations and provides physicians with a comprehensive model that allows them to incorporate patient self-testing into their practices.

Consumer Diagnostics

The Company’s consumer diagnostic products consist of the Company’s First Check brand of over-the-counter drug tests for at-home testing for up to seven illicit drugs and five prescription drugs, as well as First Check brand over-the-counter tests for cholesterol monitoring. The Company also sells Balance Activ Vaginal Gel directly to consumers and healthcare professionals for the treatment of bacterial vaginosis without antibiotics.

The Company competes with Abbott, Siemens, Beckman Coulter, Johnson & Johnson, Roche, Abaxis Medical Diagnostics, International Technidyne Corporation, INOVA Diagnostics, DiaSorin, Diamedx and Qiagen.

Advisors’ Opinion:

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market’s best stocks, it’s worth checking up on your companies’ free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That’s what we do with this series. Today, we’re checking in on Alere (NYSE: ALR  ) , whose recent revenue and earnings are plotted below.

Top 5 Heal Care Stocks To Watch Right Now: Creative Edge Nutrition Inc (FITX)

Creative Edge Nutrition Inc. (CENergy), formerly Laufer Bridge Enterprises Inc, incorporated on January 10, 2008, is engaged in the development, marketing and sales of nutraceuticals and health supplements. The Company’s product categories include lean, energy, essentials, mass, vitamins and apparel. In July 2012, it acquired Innovative Fulfillment Corp. In August 2012, the Company acquired SCD Enterprises, LLC. In September 2012, the Company acquired A-Z-Nutrition.com. In September 2012, the Company acquired Sci-Fit and Nature’s Science product brands. In March 2013, it announced its entrance into the Medical Marijuana Sector through Hemp Protein Powder, Naturals Line, Hemp-plex and Chia-plex. In May 2013, Creative Edge Nutrition Inc acquired Canadian Nutrition Super Stores.

Metabolic Xtreme utilizes the technology and advancement in weight loss technology. Cenergy’s Amino Acid Complex is the supplement for athletes, bodybuilders and anyone who’s trying to live a healthy lifestyle.

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap stocks CD International Enterprises Inc (OTCMKTS: CDII), Creative Edge Nutrition Inc (OTCMKTS: FITX) and Metrospaces Inc (OTCMKTS: MSPC) have all been the subject of recent as well as past paid for stock promotions. Of course, there is nothing wrong with properly disclosed stock promotions or investor awareness campaigns, but they can and do often backfire on unwary investors and traders alike. With that in mind, will investors and traders come out winners with these small caps or should they just be left to the promoters? Here is a quick reality check:

Top 5 Heal Care Stocks To Watch Right Now: Carpenter Technology Corp (CRS)

Carpenter Technology Corporation (Carpenter), incorporated in 1904, is engaged in the manufacturing, fabrication and distribution of specialty metals. The Company has three reportable segments: Advanced Metals Operations, Premium Alloys Operations, and Emerging Ventures., The Company develops, manufactures and distributes cast/wrought and powder metal stainless steels and special alloys, including high-temperature alloys, controlled expansion alloys, ultra high-strength alloys, implantable alloys, tool and die steels and other specialty metals, as well as cast/wrought titanium alloys. Carpenter provides material solutions to the aerospace, industrial, energy, medical, consumer products and automotive industries. In June 2011, Carpenter acquired Oilfield Alloys Pte. Ltd. In February 2012, the Company acquired Latrobe Specialty Metals, Inc.

Carpenter’s Advanced Metals Operations (AMO) segment includes the manufacturing and distribution of high-temperature and high-strength metal alloys, stainless steels, and titanium in the form of small bars and rods, wire, narrow strip and powder. Products in this segment go through more finishing operations, such as rolling, turning, grinding, drawing, and atomization, than products in its PAO segment. Also, sales in the AMO segment are spread across many end-use markets, including the aerospace, industrial, consumer, automotive, and medical industries. AMO products are sold under the Carpenter, Dynamet, Talley, Carpenter Powder Products and Aceros Fortuna brand names.

Its Premium Alloys Operations (PAO) segment includes the manufacturing and distribution of high temperature and high strength metal alloys and stainless steels in the form of ingots, billets, large bars and hollows. Also, the PAO segment includes conversion processing of metal for other specialty metals companies. A significant portion of PAO sales are to customers in the aerospace and energy industries. The Emergi ng Ventures segment includes the operations of the recently ! completed acquisitions of Amega West and Oilfield Alloys. The sales of Amega West are to customers in the energy end use market.

The Company’ s major classes of products include special alloys, stainless steels and titanium products. special alloys are used in critical components such as rings, discs and fasteners and include heat resistant alloys that range from slight modifications of stainless steels to complex nickel and cobalt base alloys as well as alloys for electronic, magnetic and electrical applications with controlled thermal expansion characteristics, or high electrical resistivity or special magnetic characteristics. Its stainless products include a range of corrositon resistant alloys including conventional stainless steels and many proprietary grades for special applications. Titanium products include corrosion resistant, specialized metal with a combination of high strength and low density.

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Carpenter Technology Corp. (NYSE: CRS) is one that remains well positioned within Aerospace materials sector, despite industry inventory adjustments still lingering. The firm believes that the value of the Athens facility is underappreciated and is likely to open sooner than the official April date. Sterne Agee also believes that 2014 will be the beginning of a multi-year growth cycle with a significant opportunity to improve cash generation. It even sees 20%+ upside to current levels as 2014 will be a transformational year.

  • [By Lee Jackson]

    Industrials: Carpenter Technology Corp. (NYSE: CRS) manufactures, fabricates and distributes specialty metals worldwide. It operates in three segments: Specialty Alloys Operations, Latrobe and Performance Engineered Products. Credit Suisse expects earnings per share growth to average 32% in fiscal years 2014 to 2016. This should be driven by double-digit growth in commercial aerospace and energy, coupled with higher incremental margins as a result of improving mix, asset utilization and Latrobe synergies. The price target for the stock is $72, though the consensus target is lower at $65. Investors are paid a 1.2% dividend. A move to the target price would represent a gain of 20%

Top 5 Heal Care Stocks To Watch Right Now: Compucon Computer Applications SA (COMP)

Compucon Computer Applications SA is a Greek company engaged mainly in the information technology sector. The Company’s activities include the manufacture and trade of electronics and software for the embroidery, telematics, laser, Web solutions and medical fields. In the embroidery field it offers album presentation or embroidery designs, lettering with a variety of fonts, frames and specialized features, and realistic three-dimensional views of embroidery designs. The Company also produces laser cutting and engraving devices for the embroidery sector. The range of telematics applications includes automotive positioning systems, fleet management and navigation systems. Its Web solutions offering includes the SiteCosmos, which is an integrated tool for on-line content management and Website design for small and medium enterprises, while the medical applications target the management of patient-oriented information, diet schedules, word processing, prescriptions and other serv ices. Advisors’ Opinion:

  • [By Wallace Witkowski]

    On the week, the Dow Jones Industrial Average (DJIA)  finished up 1.5%, the S&P 500 index (SPX)  closed up 1.4%, and the Nasdaq Composite Index (COMP)  finished 0.8% higher, even though all three indexes closed lower on Friday.

  • [By Anora Mahmudova]

    The Nasdaq Composite (COMP)  finished the day 42.50 points, or 1%, lower at 4,276.79, with the biotech stocks hit the hardest on the index . iShares Nasdaq Biotechnology ETF fell 4.7%. Friday’s losses dented the tech-heavy index’s weekly gain to 0.7%.

  • [By Anora Mahmudova]

    The Nasdaq Composite (COMP)  shed 25.71 points, or 0.68%, to 4,307.60.